BB Biotech »

Crispr Therapeutics shares owned by BB Biotech

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by BB Biotech from 13F filings

Historical chart of BB Biotech investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by BB Biotech consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by BB Biotech

Quarter filed Position value Share count Share price at filing
2019-03-31 $29M 811k 35.72

More positions owned by BB Biotech

Ionis Pharmaceuticals (IONS)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Sage Therapeutics (SAGE)
Celgene Corporation
Agios Pharmaceuticals (AGIO)
Alexion Pharmaceuticals
Alnylam Pharmaceuticals (ALNY)
Esperion Therapeutics (ESPR)
Radius Health
Halozyme Therapeutics (HALO)
Argenx Se (ARGX)
Moderna (MRNA)
Myovant Sciences

View all positions for BB Biotech

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
T. Rowe Price Investment Management
NEA Management Company
Citadel Advisors
Susquehanna International
Bank of America Corporation
Geode Capital Management
Baker Bros. Advisors
Dimensional Fund Advisors
Contrarius Investment Management
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics